ONS Guidelines™ to Support Patient Adherence to Oral Anticancer Medications.

Belcher, Sarah M.; Mackler, Emily; Muluneh, Benyam; Ginex, Pamela K.; Anderson, Mary K.; Bettencourt, Elizabeth; DasGupta, Ryan K.; Elliott, Jennifer; Hall, Erica; Karlin, Michelle; Kostoff, Diana; Marshall, Victoria K.; Millisor, Vanessa E.; Molnar, Maegan; Schneider, Susan M.; Tipton, Janelle; Yackzan, Susan; LeFebvre, Kristine B.; Sivakumaran, Kapeena; Waseem, Haya

PURPOSE: This evidence-based guideline intends to support patients, clinicians, and others regarding interventions and processes to support patient adherence to oral anticancer medications (OAMs). METHODOLOGIC APPROACH: A panel of healthcare professionals and patient representatives developed a clinical practice guideline to support patients taking OAMs. GRADE (Grading of Recommendations Assessment, Development, and Evaluation) methodology and criteria for trustworthy guidelines were followed. Risk of bias was assessed using the Cochrane Risk of Bias 2 tool. A quantitative or narrative synthesis of the evidence was completed. Certainty of the evidence was assessed using GRADE. FINDINGS: The panel agreed on recommendations and suggested an adherence risk assessment, education addressing adherence, ongoing assessment, proactive follow-up, coaching, and motivational interviewing in addition to usual care. The panel suggested the implementation of a structured OAM program. IMPLICATIONS FOR NURSING: As cancer treatment shifts from clinic to home settings, interventions and programs to support patients on OAMs are needed.

UNITED States; THERAPEUTIC use of antineoplastic agents; EVALUATION of human services programs; ORAL drug administration; MOTIVATIONAL interviewing; MEDICAL protocols; HUMAN services programs; CANCER patients; RISK assessment; DRUGS; PATIENT compliance; PATIENT education; PHYSICIANS; ONCOLOGY

Oncology Nursing Forum, 2022, Vol 49, Issue 4, p279

0190-535X

Academic Journal

10.1188/22.ONF.279-295